Shares of Anheuser-Busch InBev (NYSE: BUD) fell in pre-market trading on Thursday even as the beverage giant reported earnings for the fourth quarter of $0.86 per share which beat analysts’ consensus estimate of $0.80.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Sales increased by 3.3% year-over-year to $14.6 billion but fell short of analysts’ expectations of $15.23 billion.
Looking forward, management now expects ” EBITDA to grow in line with our medium term outlook of between 4-8% and our revenue to grow ahead of EBITDA from a healthy combination of volume and price.” The company expects to incur a capex in the range of $4.5 billion to $5 billion in FY23.
BUD stock has gained by around 1.1% year-to-date.
